Brief: Buffalo Capital says Waverly Pharma's unit entered deal to sell 2 generic cancer drugs

Waverley Pharma

15/09/2017 16:48

Sept 15 (Reuters) - Buffalo Capital Inc  BUFFp.V : 
    * Buffalo Capital Inc. announces mailing of information 
circular and provides transaction update 
    * Buffalo Capital says  Waverley Pharma International has 
entered a License, Manufacture and Supply Agreement with 
Reliance Life Sciences Private Limited 
    * Buffalo Capital Inc says  pursuant to agreement, WPI 
acquired non-exclusive license to market, sell and distribute 
WAV-101 and WAV-102 in United Kingdom 
    * Buffalo Capital says pursuant to agreement, WPI acquired 
exclusive license to market,sell,distribute WAV-101 and WAV-102, 
in U.S.,Canada,European Union 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nCNWr74Rla 
Further company coverage:  BUFFp.V  
 
 ((Bangalore.newsroom@thomsonreuters.com;))